/Companies

RxFunction

Eden Prairie, US · Minnesota corporation

Find your way into RxFunction

Sign up to see every warm intro you have to RxFunction

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the RxFunction team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

RxFunction develops Walkasins, a wearable lower limb sensory prosthesis that replaces lost nerve function for detecting and signaling foot pressure. It is intended for patients with peripheral neuropathy who have gait and balance impairments and are at high risk of falls.

Founders & leadership

LOLars Oddsson
Lars OddssonFounderLars Oddsson holds a PhD and has held faculty positions in medical device innovation and rehabilitation science at the University of Minnesota, as well as academic appointments at Karolinska Institutet, Boston University, MIT, and Harvard Medical School. He founded the Sister Kenny Research Center at Allina Health and is co-founder of RxFunction, which commercializes a wearable sensory prosthesis for patients with peripheral neuropathy.
MAMary Anderson
Mary AndersonExecutiveMary Anderson is an executive with 25 years of leadership experience in healthcare startups and medical device companies, including roles that involved product commercialization, reimbursement strategy, and customer service operations.
JD
Joseph Daniel LeachNamed on SEC filing

Board

RR
Robert RinekBoard director
RN
Richard NigonBoard director
KR
Kevin RocheBoard director
RO
Richard OfferdahlBoard director

Reported raises · per SEC filings

Form D private placements

$28.4M disclosed across 7 rounds · 2017–2022

▶$4MraisedOct 2025 · 41 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert RinekDirector
  • Richard NigonDirector
  • Kevin RocheDirector
  • Richard OfferdahlDirector
  • Mary E. AndersonExecutive Officer, Director
  • Lars OddssonExecutive Officer, Director
Offering amount
$4.3M
Amount sold
$4M
Sales commissions
$358.7K
Placement agents
Cedar Point Capital, LLC
First sale
Mar 2019
Incorporated
Corporation, Minnesota
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.5MraisedOct 2025 · 48 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Mary E. AndersonExecutive Officer, Director
  • Robert RinekDirector
  • Kevin RocheDirector
  • Richard NigonDirector
  • Richard OfferdahlDirector
  • Lars OddssonExecutive Officer, Director
Offering amount
$8.1M
Amount sold
$7.5M
Sales commissions
$769K
Placement agents
Cedar Point Capital, LLC
First sale
Dec 2017
Incorporated
Corporation, Minnesota
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedNov 2022 · 1 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard NigonDirector
  • Robert RinekDirector
  • Mary E. AndersonExecutive Officer, Director
  • Lars OddssonExecutive Officer, Director
  • Richard OfferdahlDirector
  • Kevin RocheDirector
Offering amount
$10M
Amount sold
$5M
Sales commissions
$500K
Placement agents
Cedar Point Capital, LLC
First sale
Oct 2022
Incorporated
Corporation, Minnesota
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.9MraisedMar 2022 · 2 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Mary E. AndersonExecutive Officer, Director
  • Joseph Daniel LeachExecutive Officer
  • Lars OddssonExecutive Officer, Director
  • Richard OfferdahlDirector
  • Kevin H. RocheDirector
  • Richard NigonDirector
  • Robert P. RinekDirector
Offering amount
$6M
Amount sold
$5.9M
First sale
Nov 2020
Incorporated
Corporation, Minnesota
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.9MraisedJan 2022 · 33 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin RocheDirector
  • Robert RinekDirector
  • Lars OddssonExecutive Officer, Director
  • Richard OfferdahlDirector
  • Joseph Daniel LeachExecutive Officer
  • Mary E. AndersonExecutive Officer, Director
  • Richard NigonDirector
Offering amount
$4.5M
Amount sold
$3.9M
Sales commissions
$82K
Placement agents
Cedar Point Capital, LLC
First sale
Jan 2021
Incorporated
Corporation, Minnesota
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.1MraisedMar 2018 · 2 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Lars OddssonExecutive Officer, Director
  • Joseph D. LeachExecutive Officer, Director
  • Thomas E. MorizioExecutive Officer, Director
  • Richard NigonDirector
  • Mary AndersonExecutive Officer
  • Robert RinekDirector
  • Kevin RocheDirector
Offering amount
$3.5M
Amount sold
$2.1M
Sales commissions
$350K
Proceeds to insiders
$695K
Placement agents
Cedar Point Capital, LLC
First sale
Mar 2018
Incorporated
Corporation, Minnesota
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$100KraisedAug 2017 · 1 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Lars OddssonExecutive Officer, Director
  • Joseph Daniel LeachExecutive Officer, Director
Offering amount
$2M
Amount sold
$100K
Minimum investment
$100K
First sale
Aug 2017
Incorporated
Corporation, Minnesota
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

Companies working in the same space as RxFunction.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
Department of DefenseDefense Health ProgramPhase II2020$1.1M
National Institutes of Health (NIH)National Institutes of HealthPhase II2013$1.1M
National Institutes of Health (NIH)National Institutes of HealthPhase I2011$162K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does RxFunction do?
RxFunction develops Walkasins, a wearable lower limb sensory prosthesis that replaces lost nerve function for detecting and signaling foot pressure. It is intended for patients with peripheral neuropathy who have gait and balance impairments and are at high risk of falls.
Who founded RxFunction?
RxFunction was founded by Lars Oddsson.
How much funding has RxFunction raised?
RxFunction has disclosed $28.4M raised across 7 rounds.
Where is RxFunction headquartered?
RxFunction is headquartered in Eden Prairie, US.